Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (361-370 of 536) with videos related to

Pageof 54
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
Transplantation and Cellular Therapy|June 14, 2024
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell TherapyIbrahim Aldoss, Haoyue Shan, Dongyun Yang, et al.
Haematologica|June 16, 2018
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in transplanted patientsIbrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, et al.
Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Leukemia|April 20, 2024
8-Cl-Ado and 8-NH<sub>2</sub>-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemiaJiamin Guo, Ralf Buettner, Li Du, et al.
Leukemia|July 25, 2019
Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemiaHuafeng Wang, Dandan Zhao, Le Xuan Nguyen, et al.
Blood|May 17, 2003
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B StudyClaudia D Baldus, Stephan M Tanner, Amy S Ruppert, et al.
Journal of Geriatric Oncology|November 1, 2019
Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance)Heidi D Klepin, Ellen Ritchie, Brittny Major-Elechi, et al.
Leukemia|February 20, 2024
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AMLShai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, et al.
Cancer Research|June 22, 2026
Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid LeukemiaDavid E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, et al.
Pageof 54

Showing results (361-370 of 536) with videos related to

Sort By:
Pageof 54
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
Transplantation and Cellular Therapy|June 14, 2024
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell TherapyIbrahim Aldoss, Haoyue Shan, Dongyun Yang, et al.
Haematologica|June 16, 2018
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in transplanted patientsIbrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, et al.
Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Leukemia|April 20, 2024
8-Cl-Ado and 8-NH<sub>2</sub>-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemiaJiamin Guo, Ralf Buettner, Li Du, et al.
Leukemia|July 25, 2019
Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemiaHuafeng Wang, Dandan Zhao, Le Xuan Nguyen, et al.
Blood|May 17, 2003
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B StudyClaudia D Baldus, Stephan M Tanner, Amy S Ruppert, et al.
Journal of Geriatric Oncology|November 1, 2019
Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance)Heidi D Klepin, Ellen Ritchie, Brittny Major-Elechi, et al.
Leukemia|February 20, 2024
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AMLShai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, et al.
Cancer Research|June 22, 2026
Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid LeukemiaDavid E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, et al.
Pageof 54